Virtu Financial LLC Ascendis Pharma A/S Transaction History

Virtu Financial LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	SELL	$86.1 - $127.36 $85,497 - $126,468	-993 Reduced 33.16%	2,002 $252,000
Q3 2023 Nov 14, 2023	BUY	$86.5 - $103.97 $259,067 - $311,390	2,995 New	2,995 $280,000
Q2 2022 Aug 09, 2022	SELL	$78.08 - $117.61 $138,279 - $208,287	-1,771 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$102.18 - $135.75 $182,595 - $242,585	-1,787 Reduced 50.22%	1,771 $208,000
Q4 2021 Feb 17, 2022	BUY	$127.1 - $169.66 $452,221 - $603,650	3,558 New	3,558 $479,000
Q3 2021 Nov 12, 2021	SELL	$112.67 - $176.92 $189,510 - $297,579	-1,682 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$121.62 - $145.29 $204,564 - $244,377	1,682 New	1,682 $221,000
Q4 2020 Feb 24, 2021	SELL	$151.2 - $182.76 $270,194 - $326,592	-1,787 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$134.29 - $154.32 $239,976 - $275,769	1,787 New	1,787 $276,000
Q3 2019 Nov 20, 2019	SELL	$95.8 - $118.9 $525,271 - $651,928	-5,483 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$107.11 - $132.09 $376,920 - $464,824	3,519 Added 179.18%	5,483 $631,000
Q1 2019 Apr 12, 2019	SELL	$62.15 - $129.99 $94,095 - $196,804	-1,514 Reduced 43.53%	1,964 $231,000
Q1 2018 May 14, 2018	BUY	$38.98 - $68.04 $135,572 - $236,643	3,478 New	3,478 $227,000

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.